Two decades ago, it was reported that the presence of either CD3+ or CD8+ tumor-infiltrating lymphocytes in epithelial ovarian cancer was associated with improved overall survival and increased tumor expression of interferon-gamma and other lymphocyte-attracting cytokines indicating that the immune system was active against ovarian cancer [56]. Here, CD8A is linked to neoplasm.